Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Dec 19 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-19-2024-2

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 19, 2024, titled "Zydus receives final approval from USFDA for Lidocaine and Prilocaine Cream USP, 2.5%/2.5%".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases